Sage Journals: Discover world-class research

Retricted access

Case report

First published 2023-03-28

Varicella in the neonatal ICU due to the Varicella vaccine Oka strain

I. Frantzis, M. Messina, J.M. Taylor [...]

Journal of Neonatal-Perinatal Medicine

Retricted access

Research article

First published 1983-9

Immunogenicity of Wild and Attenuated Varicella-Zoster Virus Strains in Pygmy Marmosets

Yoshizo Asano, Paul Albrecht, James H. Vickers

Experimental Biology and Medicine

Open access

Research article

First published 2018

Xanthine-based acyclic nucleoside phosphonates with potent antiviral activity against varicella-zoster virus and human cytomegalovirus

Ondřej Baszczyňski, Martin Maxmilian Kaiser, Michal Česnek [...]

Antiviral Chemistry and Chemotherapy

Retricted access

Research article

First published 1994-1

Immune Response to Secondary Immunization with Live or Inactivated VZV Vaccine in Elderly Adults

Anthony R. Hayward, Kim Buda, Myron J. Levin

Viral Immunology

Retricted access

Research article

First published 1999-9

Differential Neutralizing Antibody Responses to Varicella-Zoster Virus Glycoproteins B and E Following Naked DNA Immunization

Marc Massaer, Michele Haumont, Lida Garcia [...]

Viral Immunology

Free access

Research article

First published 2016-1

Efficacy of varicella (VZV) vaccination: an update for the clinician

Lili Wang, Lucy Zhu, Hua Zhu

Therapeutic Advances in Vaccines and Immunotherapy

Open access

Research article

First published 2020

Evaluation of immunogenicity,safety and breakthrough following administration of live attenuated varicella vaccine in two doses three months apart regimen in Indian children

Monjori Mitra, Jaydeep Chowdhury, Surupa Basu [...]

Therapeutic Advances in Vaccines and Immunotherapy

Search results

Varicella in the neonatal ICU due to the Varicella vaccine Oka strain

Immunogenicity of Wild and Attenuated Varicella-Zoster Virus Strains in Pygmy Marmosets

Xanthine-based acyclic nucleoside phosphonates with potent antiviral activity against varicella-zoster virus and human cytomegalovirus

Immune Response to Secondary Immunization with Live or Inactivated VZV Vaccine in Elderly Adults

Differential Neutralizing Antibody Responses to Varicella-Zoster Virus Glycoproteins B and E Following Naked DNA Immunization

Efficacy of varicella (VZV) vaccination: an update for the clinician

Evaluation of immunogenicity,safety and breakthrough following administration of live attenuated varicella vaccine in two doses three months apart regimen in Indian children